info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » therapeutics

therapeutics

Merkel Cell Carcinoma Treatment Market By Treatment Type (Immunotherapy, Chemotherapy, Radiation Therapy, Surgery); By Stage of Disease (Early-Stage MCC, Advanced-Stage MCC); By End-User (Hospitals, Cancer Treatment Centers, Dermatology Clinics, Outpatient Clinics); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Merkel Cell Carcinoma Treatment Market is expected to be valued at USD 0.45 billion in 2024 and is projected to reach USD 0.88 billion by... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Inclusion Body Myositis Market By Treatment Type (Symptomatic Therapies, Off-label Immunotherapies, Experimental Drugs); By Route of Administration (Oral, Subcutaneous, Intramuscular); By End User (Tertiary Hospitals, Outpatient Clinics, Rehab Centers, Home Health Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Inclusion Body Myositis Market will witness a moderate CAGR of 5.6%, valued at around $1.42 billion in 2024 and expected to reach nearly $1.98 billion by 2030,Read More

Published Date: JAN-2026 | No Of Pages:192 | $ 4485

Metabolic Acidosis Market By Treatment Type (Bicarbonate Therapy, Dialysis, Pharmaceutical Interventions); By Diagnostic Method (Blood Gas Analyzers, Urinalysis, Continuous Monitoring Devices); By End User (Hospitals, Dialysis Centers, Outpatient Care Clinics, Specialized Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Metabolic Acidosis Market is poised to experience steady growth, with the global market size valued at USD 3.2 billion in 2024, projected to reach USD 5.6 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Kidney Transplant Rejection Market By Product Type (Immunosuppressive Drugs, Biologics, Diagnostics, Digital Health Tools); By Diagnostic Approach (Tissue Biopsy, Blood-Based Biomarkers, Molecular Diagnostics, AI-Based Platforms); By End User (Transplant Centers, Community Hospitals, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Kidney Transplant Rejection Market is projected to expand at a healthy pace through 2030, driven by ongoing advances in immunosuppressive therapy, precision diagnostics, and digital health monitoring, acco... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Medulloblastoma Drug Market By Drug Type (Chemotherapy, Targeted Therapy, Immunotherapy, Biologics); By Route of Administration (Oral, Intravenous, Intrathecal); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); By End User (Pediatric Hospitals, General Hospitals, Diagnostic Imaging Centers, Research Institutions), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Medulloblastoma Drug Market is projected to witness a significant growth rate in the forecast period from 2024 to 2030, with the market valued at USD 1.5 billionRead More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

RNA Interference (RNAi) Drug Delivery Market By Drug Type (siRNA, miRNA); By Delivery Platform (Lipid Nanoparticles, GalNAc Conjugates, Polymeric Carriers, Exosomes); By Application (Genetic & Rare Diseases, Oncology, Cardiovascular & Metabolic, Neurological Disorders); By Route of Administration (Intravenous, Subcutaneous, Intrathecal/Inhalable); By End User (Hospitals, Specialty Clinics, Homecare Settings, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Executive Introduction and Strategic Overview

The Global RNA Interference (RNAi) Drug Delivery Market is projected to grow at an 18.9% CAGR, expanding from USD 1.47 billion in 2024 to USD 4.12... Read More

Published Date: SEP-2025 | No Of Pages:190 | $ 4485

Cancer Cachexia Market By Therapeutic Approach (Pharmacological Therapies, Nutritional Interventions, Multimodal Therapy); By Product Type (Pharmaceuticals, Nutraceuticals & Medical Nutrition, Medical Devices & Exercise Aids); By End User (Hospitals & Cancer Specialty Centers, Ambulatory & Outpatient Clinics, Homecare & Palliative Services); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Cachexia Market will advance at a steady CAGR of 6.8%, valued at USD 3.8 billion in 2024, and projected to reach nearly US... Read More

Published Date: DEC-2025 | No Of Pages:178 | $ 4485

Penile Cancer Treatment Market By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy); By Route of Administration (Oral, Injectable, Localized); By End User (Hospitals, Specialty Cancer Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Penile Cancer Treatment Market will witness a steady CAGR of 6.8%, valued at USD 280 million in 2024 and expected to reach USD 415 million by 2030, accord... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

Egg Donation Market By Donor Type (Fresh Donor Eggs, Frozen Donor Eggs); By Service Channel (Fertility Clinics & ART Centers, Egg Banks & Agencies, Hospitals & Maternity Centers); By End User (Heterosexual Couples, Single Women & Same-Sex Couples, Research & Academic Use); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Egg Donation Market will expand at an estimated CAGR of 8.1% , valued at USD 2.5 billion in 2024 , and projected to reach USD 4.2 billion by 2030 , confir... Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

Drug Addiction Treatment Market By Treatment Type (Pharmacological, Non-Pharmacological); By Drug Type (Opioids, Alcohol, Nicotine, Stimulants, Polysubstance); By End User (Hospitals, Specialty Clinics, Digital Health Platforms, Correctional Facilities); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global Drug Addiction Treatment Market is projected to reach $31.7 billion by 2030, rising from $19.2 billion in 2024 at a steady 8.7% CAGR (2024–2030), dr... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

Ascites Market By Treatment Type (Paracentesis, Diuretic Therapy, Implantable Devices, Peritoneovenous Shunts, Investigational Pharmacologics); By Disease Etiology (Cirrhosis-Induced, Malignant, Cardiac, Others); By End User (Hospitals, ASCs, Specialty Clinics, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ascites Market is projected to grow at a 6.8% CAGR, rising from USD 3.9 billion in 2024 to USD 5.9 billion by 2030, driven by increasing liver disease pre... Read More

Published Date: DEC-2025 | No Of Pages:161 | $ 4485

Peptide Cancer Vaccine Market By Vaccine Type (Synthetic Peptide Vaccines, Personalized Peptide Vaccines); By Cancer Type (Melanoma, Non-Small Cell Lung Cancer, Triple-Negative Breast Cancer, Pancreatic Cancer, Glioblastoma); By Delivery Mechanism (Peptides Alone, Peptides with Adjuvants, Peptides with RNA/DNA Vectors); By End User (Academic Hospitals, Specialty Oncology Clinics, Biopharmaceutical Companies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peptide Cancer Vaccine Market is projected to grow at a robust 24.9% CAGR, rising from USD 1.2 billion in 2024 to over USD 4.6 billion by 2030, driven by ... Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

Direct Oral Anticoagulants Market By Product Type (Apixaban, Rivaroxaban, Dabigatran, Edoxaban); By Application (Atrial Fibrillation, Venous Thromboembolism, Orthopedic Prophylaxis, Stroke Prevention); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Direct Oral Anticoagulants Market is projected to grow at a CAGR of 8.7%, rising from USD 28.6 billion in 2024 to nearly USD 47.3 billion by 2030, driven ... Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

Pneumothorax Treatment Market By Treatment Type (Needle Aspiration, Chest Tube Drainage, Surgical Interventions [VATS, Pleurodesis, Thoracotomy], Supportive Care & Pharmacological Management); By End User (Hospitals & Trauma Centers, Ambulatory Surgical Centers, Emergency Medical Services, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pneumothorax Treatment Market is projected to grow at a 6.1% CAGR, rising from USD 2.1 billion in 2024 to USD 3.2 billion by 2030, driven by trauma incide... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Acute Respiratory Infection Market By Infection Type (Upper Respiratory Tract Infections, Lower Respiratory Tract Infections); By Pathogen Type (Viral, Bacterial, Others); By Treatment Type (Antibiotics, Antivirals, Immunomodulators, Supportive Care); By End User (Hospitals, Clinics, Ambulatory Care Centers, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Respiratory Infection Market is projected to grow from USD 69.1 billion in 2024 to USD 94.6 billion by 2030, registering a steady 5.4% CAGR, driven ... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Aicardi Goutieres Syndrome Market By Treatment Type (Symptomatic Therapy, Experimental/Investigational Therapies); By Route of Administration (Oral, Parenteral, Emerging Routes); By End User (Specialty Hospitals, Academic & Research Institutes, Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aicardi Goutieres Syndrome (AGS) Market is projected to grow at a 7.8% CAGR, increasing from USD 92 million in 2024 to USD 154 million by 2030, driven by ... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Chronic Venous Insufficiency Treatment Market By Treatment Type (Compression Therapy, Pharmacological Therapy, Endovenous Ablation, Sclerotherapy, Surgical Vein Stripping); By Disease Severity (Early-Stage CVI, Moderate CVI, Severe CVI); By End User (Hospitals, Specialized Vascular Clinics, Ambulatory Surgical Centers, Diagnostic & Primary Care Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Venous Insufficiency Treatment Market will grow at a CAGR of 6.5% , valued at USD 3.9 billion in 2024 , and expected to reach USD 6.1 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Chronic Thromboembolic Pulmonary Hypertension Market By Treatment Modality (Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, Pharmacotherapy); By Drug Class (Soluble Guanylate Cyclase Stimulators, Prostacyclin Analogs, Endothelin Receptor Antagonists, Anticoagulants); By End User (Specialized CTEPH Centers, Tertiary Hospitals, General Hospitals, Diagnostic & Outpatient Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Market will witness a robust CAGR of 6.8% , valued at USD 1.7 billion in 2024 , exp... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Cocaine Intoxication Treatment Market By Product Type (Benzodiazepines, Cardiovascular Stabilizers, Antipsychotics, Emerging Pharmacotherapies); By Route of Administration (Oral, Intravenous, Intramuscular, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cocaine Intoxication Treatment Market is projected to expand steadily between 2024 and 2030, growing at an CAGR of 6.5% . The market is valued at USD 1.8 billion in 2024 a... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Complement 3 Glomerulopathy Treatment Market By Drug Class (Complement Inhibitors, Immunosuppressants, Corticosteroids, Others); By Route of Administration (Intravenous, Oral, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Complement 3 Glomerulopathy Treatment Market will witness a robust CAGR of 10.2%, valued at USD 615.0 million in 2024 , expected to reach... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Cold Agglutinin Disease Treatment Market By Drug Class (Monoclonal Antibodies, Immunosuppressants, Others); By Route of Administration (Intravenous, Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cold Agglutinin Disease ( CAD ) Treatment Market will witness a steady CAGR of 8.1%, valued at USD 620.0 million... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Vernal Keratoconjunctivitis Market By Drug Class (Antihistamines & Mast Cell Stabilizers, Corticosteroids, Immunomodulators, Biologics); By Route of Administration (Eye Drops, Gels, Ocular Inserts); By Patient Age Group (Pediatric, Adolescent, Adult-Onset); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Vernal Keratoconjunctivitis Market is projected to grow at a CAGR of 6.8% , valued at USD 332.0 million in 2024 , and ex... Read More

Published Date: DEC-2025 | No Of Pages:190 | $ 4485

Rare NRG1 Fusion Market By Therapy Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, RNA Therapies & Antibody-Drug Conjugates); By Cancer Type (Non-Small Cell Lung Cancer, Pancreatic Cancer, Others); By Diagnostic Method (CGP via NGS, FISH & RT-PCR); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rare NRG1 Fusion Market is forecasted to grow at a dynamic CAGR of 37.8%, rising from $ 187.0 million in 2024 to $1.42 billion by 2030, supported by Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Non-Cystic Fibrosis Bronchiectasis Market By Treatment Type (Inhaled Antibiotics, Oral Antibiotics, Bronchodilators, Anti-inflammatory Therapies); By Diagnostic Modality (High-Resolution CT, Pulmonary Function Testing, Microbiological Testing); By End User (Hospitals, Pulmonology Clinics, Specialty Pharmacies, Homecare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Cystic Fibrosis Bronchiectasis Market is expected to expand at a CAGR of 6.5%, rising from USD 1.4 billion in 2024 to USD 2.1 billion by 2030, support... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Neoantigen Cancer Vaccine Market By Technology Platform (mRNA-based, Peptide-based, DNA-based, Dendritic Cell-based); By Cancer Type (Melanoma, NSCLC, Colorectal, Pancreatic, Glioblastoma, Others); By Delivery Mechanism (Lipid Nanoparticle, Intradermal Injection, Electroporation); By End User (Academic Cancer Centers, Specialty Oncology Hospitals, CROs, Immunotherapy Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neoantigen Cancer Vaccine Market will register rapid growth at a compelling CAGR of 24.7% from 2024 to 2030, growing from USD 1.2 billion in 2024 to USD 4.5 billio... Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

mRNA Therapeutics Market By Product Type (mRNA Vaccines, mRNA Therapeutics); By Application (Infectious Diseases, Oncology, Genetic Disorders, Autoimmune Diseases, Cardiovascular and Others); By Route of Administration (Intramuscular, Intravenous, Inhalation/Intranasal); By End User (Hospitals & Academic Centers, Public Health Agencies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global mRNA Therapeutics Market is poised for high growth, increasing from USD 45.2 billion in 2024 to USD 98.7 billion by 2030, registering a CAGR of 13.9%, dri... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Intratumoral Cancer Therapies Market By Therapy Type (Oncolytic Viruses, Cytokine-Based Therapies, Gene Therapies, Small Molecule Injectables); By Cancer Type (Melanoma, Head and Neck, Breast, Lung, Pancreatic, Brain Tumors); By Route of Administration (Image-Guided Injection, Intraoperative Delivery, Endoscopic Injection); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Intratumoral Cancer Therapies Market is projected to experience dynamic growth at a solid CAGR of 10.6%, valued at USD 1.3 billion in 2024, and projected to surpass Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Interstitial Lung Disease Market By Disease Type (IPF, CTD-ILD, HP, Occupational/Environmental, Sarcoidosis, Drug-Induced, Others); By Drug Class (Antifibrotics, Corticosteroids, Immunosuppressants, Biologics, Novel Agents); By Route of Administration (Oral, Inhalation, Injectable); By Diagnostic Tool (HRCT, PFTs, Biomarkers, Genetic Testing, Lung Biopsy); By End User (Tertiary Hospitals, Specialist Clinics, Imaging Centers, Community Hospitals, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Interstitial Lung Disease Market is anticipated to grow at a sustainable CAGR of around 6.1%, increasing from USD 4.7 billion in 2024 to nearly USD 6.7 billion by ... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

IgA Nephropathy Market By Therapy Type (Corticosteroid-Sparing Therapies, Endothelin Receptor Antagonists, Complement Inhibitors, Supportive Care); By Route of Administration (Oral, Injectable); By End User (Academic and Tertiary Hospitals, Specialty Nephrology Clinics, Retail and Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global IgA Nephropathy Market is set to register steady expansion at a CAGR of 6.5%, growing from USD 3.8 billion in 2024 to USD 5.8 billion by 2030, driven by <... Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

HER2 Positive Gastric Cancer Market By Therapy Type (Monoclonal Antibodies, Antibody-Drug Conjugates, Tyrosine Kinase Inhibitors, Immunotherapies); By Line of Treatment (First-Line, Second-Line, Third-Line & Beyond); By Diagnostic Modality (IHC, FISH, NGS); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global HER2 Positive Gastric Cancer Market will witness a steady CAGR of 6.8% , valued at USD 3.7 billion in 2024 , and projected to reach nearl... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Hematopoietic Stem Cells Transplantation Market By Transplant Type (Autologous, Allogeneic); By Source of Stem Cells (Bone Marrow, Peripheral Blood, Umbilical Cord Blood); By Application (Oncology, Hematology, Rare Genetic Disorders); By End User (Academic Hospitals, General Hospitals, Specialty Transplant Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hematopoietic Stem Cells Transplantation (HSCT) Market is set to advance at a healthy CAGR of 8.1%, reaching USD 10.7 billion by 2030 from USD 6.7 billion in 2024<... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Fibromyalgia Treatment Market By Drug Class (SNRIs, Anticonvulsants, Tricyclic Antidepressants, Muscle Relaxants, Others); By Route of Administration (Oral, Topical, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fibromyalgia Treatment Market will grow at a compound annual growth rate of 5.2 %, rising from USD 3.6 billion in 2024 to USD 4.88 billion by 2030, fueled... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

DiGeorge Syndrome Drug Market By Drug Class (Immunomodulators and Immunoglobulins, Hormone Replacement Therapies, Antipsychotics and Behavioral Medications, Supportive Medications); By Therapeutic Target (Immune System Dysfunction, Endocrine and Metabolic Dysfunction, Neurodevelopmental and Psychiatric Symptoms, Congenital Heart Defects and Surgical Support); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail Pharmacies and Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Digeorge Syndrome Drug Market is projected to grow at a CAGR of 8.1% from 2024 to 2030 , moving from an estimated USD 328Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Cutaneous Lupus Erythematosus Market By Disease Subtype (Acute CLE, Subacute CLE, Chronic CLE); By Treatment Class (Topical Agents, Antimalarials, Immunosuppressants, Biologics & Small Molecules); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cutaneous Lupus Erythematosus (CLE) Market will witness steady expansion at a CAGR of 6.4%, reaching USD 3.1 billion by 2030 from USD 2.1 billion in 2024,... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

Chronic Spontaneous Urticaria Treatment Market By Treatment Type (Antihistamines, Biologics, Leukotriene Receptor Antagonists, Corticosteroids, Others); By Route of Administration (Oral, Injectable, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Spontaneous Urticaria (CSU) Treatment Market is projected to expand steadily between 2024 and 2030, driven by a combination of rising disease prev... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

Chronic Rhinosinusitis With Nasal Polyps Market By Treatment Type (Corticosteroids, Biologics, Surgery, Others); By Route of Administration (Intranasal, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Rhinosinusitis With Nasal Polyps Market will expand at a stable CAGR of 6.8%, growing from USD 5.1 billion in 2024 to USD 7.6 billion by 2030, fue... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market By Drug Class (Bronchodilators, Corticosteroids, PDE-4 Inhibitors, Combination Therapies, Others); By Route of Administration (Inhalation, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market is projected to grow at a steady CAGR of 6.1%, with an estimated value of USD 20.1 billion in 2024 and a fore... Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Chronic Lymphocytic Leukemia Market By Therapy Type (Chemo-Immunotherapy, BTK Inhibitors, BCL2 Inhibitors, Others); By Diagnostics (MRD Assays, Cytogenetic Testing, Flow Cytometry, Others); By End User (Hospitals, Specialist Clinics, Outpatient Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chronic Lymphocytic Leukemia Market is set to rise at a CAGR of 6.1%, increasing from 10.6 billion US dollars in 2024 to approximately 15.1 billion US dollars by 2... Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Chronic Inducible Urticaria Treatment Market By Drug Class (Antihistamines, Leukotriene Receptor Antagonists, Biologics, Immunosuppressants); By Route of Administration (Oral, Subcutaneous, Others); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chronic Inducible Urticaria Treatment Market is projected to rise from $1.3 billion in 2024 to $2.1 billion by 2030, registering a CAGR of 8.2%, driven by... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Chondrosarcoma Market By Type (Conventional, Dedifferentiated, Mesenchymal, Clear Cell); By Treatment Modality (Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy); By End User (Academic Hospitals, Orthopedic Oncology Centers, Community Hospitals, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chondrosarcoma Market is projected to grow from USD 1.2 billion in 2024 to nearly USD 1.80 billion by 2030, reflecting a CAGR of 7.3 %, driven by ... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Chemotherapy-Induced Diarrhea Treatment Market By Treatment Type (Anti-Diarrheal Agents, Oral Rehydration Solutions, Probiotics, Biologics); By Chemotherapy Regimen (Fluoropyrimidines, Irinotecan, Combination Therapies, Others); By End User (Hospitals & Oncology Centers, Outpatient Clinics & Homecare, Pharmacies & Retail); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chemotherapy-Induced Diarrhea Treatment Market is projected to witness a robust CAGR of 6.8%, valued at USD 1.2 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Chemotherapy Induced Peripheral Neuropathy Treatment Market By Drug Class (Antidepressants, Anticonvulsants, Topical Agents, Opioids, Neuroprotective Agents); By Mechanism of Action (Pain Modulation, Neuroprotection, Nerve Regeneration); By Route of Administration (Oral, Injectable, Transdermal); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Chemotherapy Induced Peripheral Neuropathy ( CIPN ) Treatment Market is projected to grow at a CAGR of 7.3 %, reaching a... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Checkpoint Inhibitor Refractory Cancer Market By Therapy Type (T-cell Engagers, Next-Generation Checkpoint Modulators, Cell Therapies, Small Molecule Immunomodulators, Combination Therapies); By Cancer Type (Melanoma, NSCLC, RCC, HNSCC, Others); By End User (Academic Cancer Centers, Specialty Oncology Clinics, General Hospitals, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Checkpoint Inhibitor Refractory Cancer Market will witness a robust CAGR of 9.6%, valued at USD 8.3 billion in 2024, and expected to reach around USD 14.4 billion ... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

CD38 Monoclonal Antibody Drugs Market By Therapy Type (Monotherapy, Combination Therapy); By Indication (Multiple Myeloma, Chronic Lymphocytic Leukemia, Autoimmune Disorders, Other Hematologic Malignancies); By Distribution Channel (Hospital Pharmacies, Community Oncology Clinics, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD38 Monoclonal Antibody Drugs Market is projected to expand steadily between 2024 and 2030 , with an estimated value of USD 8.1 billion in 2024 and likel... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Catheter Related Bloodstream Infection Market By Product Type (Antimicrobial Catheters, CHG Dressings, Needleless Connectors, Catheter Lock Solutions); By Pathogen Type (Gram-Positive Bacteria, Gram-Negative Bacteria, Fungal Pathogens); By End User (Hospitals, Dialysis Clinics, Infusion Centers, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Catheter-Related Bloodstream Infection (CRBSI) Market is projected to grow at a steady CAGR of 6.5%, reaching USD 2.35 billion by 2030 from USD 1.6 billion in 2024... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Cardiac Amyloidosis Market By Product Type (Transthyretin Stabilizers, RNA Interference Therapies, Antisense Oligonucleotides, Monoclonal Antibodies, Diagnostics); By Application (Transthyretin Amyloidosis [Hereditary, Wild-type], Light Chain Amyloidosis); By End User (Hospitals, Specialty Cardiac Centers, Diagnostic Laboratories, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Amyloidosis Market will grow at a CAGR of 10.8% , valued at USD 4.2 billion in 2024 , and projected to reach USD 7.8 billion by 2030 , according t... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Cancer Anorexia Market By Product Type (Appetite Stimulants, Corticosteroids, Progestogens, Cannabinoids, Nutraceuticals, Biologics/Peptides); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Anorexia Market is expected to grow at a CAGR of 6.8% , valued at USD 2.9 billion in 2024 , and projected to reach USD 4.3 billion by 2030 , accord... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

Bullous Keratopathy Market By Treatment Type (Corneal Transplantation [DMEK, DSAEK, Penetrating Keratoplasty], Pharmacological Therapy, Artificial Corneas, Supportive & Symptomatic Treatment); By Cause (Post-Cataract Surgery, Fuchs’ Dystrophy, Trauma, Infection, Congenital Disorders); By End User (Specialty Eye Hospitals, General Hospitals, ASCs, Academic/Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bullous Keratopathy Market is projected to grow steadily from USD 1.12 billion in 2024 to reach around USD 1.61 billion by 2030 , reflecting a CAG... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Bronchopulmonary Dysplasia Treatment Market By Treatment Type (Corticosteroids, Surfactants, Diuretics, Bronchodilators, Pulmonary Vasodilators); By Route of Administration (Intravenous, Inhalation, Oral, Intratracheal); By End User (NICUs, Pediatric Hospitals, Outpatient Pediatric Clinics, Community Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bronchopulmonary Dysplasia (BPD) Treatment Market is projected to expand steadily between 2024 and 2030, supported by rising preterm birth rates and advances in neonatal intensive care. Ba... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

BRCA Mutations Treatment Market By Treatment Type (PARP Inhibitors, Hormonal Therapy, Chemotherapy, Targeted Combinations); By Cancer Type (Breast Cancer, Ovarian Cancer, Prostate Cancer, Pancreatic and Others); By End User (Hospitals and Cancer Centers, Specialty Oncology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global BRCA Mutations Treatment Market is projected to reach a value of $5.8 billion in 2024 , with expectations to surpass $10.2 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Bone Metastasis Market By Treatment Type (Pharmaceuticals [Bisphosphonates, RANKL Inhibitors, Radiopharmaceuticals], Radiation Therapy, Surgical Interventions, Supportive Care); By Cancer Type (Breast Cancer, Prostate Cancer, Lung Cancer, Kidney Cancer, Thyroid & Others); By End User (Hospitals & Cancer Centers, Community Oncology Clinics, Specialty Orthopedic Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bone Metastasis Market is expected to witness sustained growth, reaching USD 18.7 billion in 2024 and anticipated to cross USD 27.9 billion by 2030, reflecting a C... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Blepharitis Market By Type of Blepharitis(Anterior Blepharitis, Posterior Blepharitis, Mixed); By Treatment Type (Lid Hygiene Products, Prescription Pharmaceuticals, In-Office Procedures, Device-Based Home Therapies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Blepharitis Market is projected to expand steadily between 2024 and 2030, growing at an CAGR of 5.8%, reaching approximately USD 1.9 billion in 2024 and estimated to cross... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Biliary Atresia Market By Treatment Type (Surgical Interventions, Liver Transplantation, Pharmacological Therapies); By Diagnosis Stage (Early Diagnosis, Delayed Diagnosis); By End User (Tertiary Pediatric Hospitals, Specialty Liver Transplant Units, General Hospitals with Pediatric Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biliary Atresia Market is projected to expand steadily between 2024 and 2030, driven by rising awareness of neonatal liver disorders, earlier diagnostic interventions, and ongoing advances... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Beta Thalassemia Market By Therapy Type (Blood Transfusions, Iron Chelation Therapy, Gene Therapy & Gene Editing, Bone Marrow/Stem Cell Transplantation); By Route of Administration (Intravenous, Oral); By End User (Hospitals & Hematology Centers, Specialty Clinics, Retail & Online Pharmacies, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Beta Thalassemia Market is projected to expand steadily between 2024 and 2030, valued at USD 1.9 billion in 2024 and expected to reach USD 3.1 billion by 2030, reflecting ... Read More

Published Date: DEC-2025 | No Of Pages:161 | $ 4485

Benign Prostatic Hyperplasia Treatment Market By Therapy Type (Pharmacological, Minimally Invasive Surgical Therapies, Surgical Procedures); By Procedure Setting (Hospitals, Ambulatory Surgical Centers, Urology Clinics); By End User (Hospitals & Teaching Institutions, Specialty Urology Centers, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Benign Prostatic Hyperplasia Treatment Market is expected to expand at a 6.9% CAGR, rising from $10.8 billion in 2024 to $16.1 billion by 2030, supported ... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

AXL Receptor Tyrosine Kinase Inhibitors Market By Molecule Type (Small Molecule Inhibitors, Monoclonal Antibodies, Antibody-Drug Conjugates); By Application (Oncology, Fibrosis, Inflammatory Diseases); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global AXL Receptor Tyrosine Kinase (RTK) Inhibitors Market is anticipated to grow steadily between 2024 and 2030, with analysts estimating a ma... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Axial Spondyloarthritis Market By Drug Type (Biologics, csDMARDs, tsDMARDs); By Disease Type (Radiographic AxSpA, Non-Radiographic AxSpA); By End User (Hospitals, Specialty Rheumatology Clinics, Ambulatory Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Axial Spondyloarthritis Market will experience consistent growth at a CAGR of 7.4 %, increasing from USD 5.2 billion in 2024 to USD 7.98 billion by 2030, ... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Trodelvy Market By Indication (Triple-Negative Breast Cancer, HR+/HER2- Breast Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Others); By Line of Therapy (Second-Line, Third-Line and Beyond, Maintenance); By Distribution Channel (Hospital Pharmacies, Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trodelvy Market will experience a strong growth trajectory between 2024 and 2030, rising from an estimated USD 1.62 billion in 2024 to nearly USD ... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

PIM Kinase Targeted Therapies Market By Drug Type (Selective PIM Kinase Inhibitors, Dual/Multi-Target Kinase Inhibitors); By Cancer Type (Hematologic Malignancies, Solid Tumors); By Line of Therapy (First-Line, Second-Line and Beyond); By Route of Administration (Oral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PIM Kinase Targeted Therapies Market is projected to witness strong expansion between 2024 and 2030, with an inferred CAGR of 10.1%. The market is valued at approximately ... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

Lupus Nephritis Treatment Market By Drug Class (Immunosuppressants, Biologics, Corticosteroids, ACE Inhibitors & ARBs, Antimalarials); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lupus Nephritis Treatment Market is projected to grow at a CAGR of 10.4%, expanding from USD 1.6 billion in 2024 to approximately USD 2.9 billion ... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

CD40 Targeted Therapies Market By Therapy Type (Monoclonal Antibodies, Fusion Proteins, Small Molecules); By Indication (Oncology, Autoimmune Diseases, Transplantation); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD40 Targeted Therapies Market is projected to grow at a robust CAGR of 11.8%, reaching an estimated valuation of USD 3.9 billion by 2030... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Protein Misfolding & Aggregation Disorder Therapies (PMADT) Market By Target Protein (Amyloid-β, Tau, α-Synuclein, Huntingtin, TDP-43, Others); By Therapeutic Modality (Monoclonal Antibodies, RNA/Antisense Therapies, Small Molecule Modulators, Gene Therapy & Advanced Platforms); By Indication (Alzheimer’s, Parkinson’s, ALS, Huntington’s, Rare Proteinopathies); By Line of Therapy; By Region, Segment Revenue Estimation, Forecast, 2025–2035

1. Introduction and Strategic Context

The global Protein Misfolding & Aggregation Disorder Therapies (PMADT) Market is projected to reach USD 1.7 billion by 2035, up from around USD 0.6 billion in 2025, growing at... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

PLK Targeted Therapies Market By Drug Type (PLK1 Inhibitors, Multi-Kinase Inhibitors); By Cancer Indication (Acute Myeloid Leukemia, Prostate Cancer, Ovarian Cancer, Breast Cancer, NSCLC); By Line of Therapy (First-Line, Second-Line, Maintenance/Combo Therapy); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PLK Targeted Therapies Market is expanding at a robust 8.5% CAGR, rising from USD 1.1 billion in 2024 to nearly USD 1.9 billion by 2030, driven by PLK1 in... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Gamma Delta T Cell Cancer Therapy Market By Therapy Type (Allogeneic, Autologous); By Cancer Indication (Hematologic Malignancies, Solid Tumors); By Delivery Method (Non-Engineered, Genetically Modified); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gamma Delta T Cell Cancer Therapy Market is projected to grow at a robust 32.6% CAGR, rising from USD 318 million in 2024 to approximately USD 2.1 billion by 2030<... Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

Cancer Photodynamic Therapy (PDT) Market By Product Type (Photosensitizing Agents, Light Delivery Systems); By Cancer Application (Lung Cancer, Esophageal Cancer, Bladder Cancer, Head & Neck Cancer, Skin Cancer, Others); By End User (Hospitals, Cancer Specialty Centers, Ambulatory Surgical Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Photodynamic Therapy (PDT) Market is projected to grow at a 8.9% CAGR, rising from USD 1.5 billion in 2024 to USD 2.7 billion by 2030, driven by ad... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

CD5 Targeting Therapies Market By Therapy Type (Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Small Molecule Inhibitors); By Indication (Hematologic Malignancies, Autoimmune Disorders, Graft-Versus-Host Disease); By End User (Hospitals and Cancer Centers, Academic and Research Institutes, Specialty Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD5 Targeting Therapies Market is projected to grow at a 10.4% CAGR, rising from USD 1.8 billion in 2024 to USD 3.6 billion by 2030, driven by advances in... Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

Trigeminal Neuralgia Treatment Market By Treatment Type (Pharmacological Therapy, Surgical Procedures, Non-Invasive Therapies); By Drug Class (Anticonvulsants, Muscle Relaxants, Antidepressants, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trigeminal Neuralgia Treatment Market is valued at USD 675 million in 2024 and projected to reach USD 1.02 billion by 2030, expanding at a 7.1% CAGR, driv... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

DLL3 Targeted Therapies Market By Therapy Type (Antibody-Drug Conjugates, Bispecific Antibodies, Small Molecules, Cell Therapies); By Indication (Small Cell Lung Cancer, Large Cell Neuroendocrine Carcinoma, Other DLL3-Positive Tumors); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Cancer Specialty Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DLL3 Targeted Therapies Market is valued at USD 472.5 million in 2024 and projected to reach USD 1.34 billion by 2030, growing at a robust 18.9% CAGR, dri... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

CD123 Targeted Therapy Market By Therapy Type (Antibody-Drug Conjugates, Monoclonal Antibodies, Bispecific Antibodies, CAR-T Therapies); By Application (Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Myelodysplastic Syndromes, Others); By End User (Academic & Research Hospitals, Cancer Specialty Centers, Community Hospitals & Clinics, CROs & Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD123 Targeted Therapy Market is projected to grow from USD 2.1 billion in 2024 to USD 5.3 billion by 2030, registering a strong 16.7% CAGR, driven b... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Targeted Alpha Therapy Market By Isotope Type (Actinium-225, Thorium-227, Bismuth-213, Others); By Therapeutic Area (Prostate Cancer, Leukemia, Glioblastoma, Neuroendocrine Tumors, Others); By End User (Academic Cancer Centers, Oncology Hospitals, Radiopharmacies & Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Targeted Alpha Therapy Market is projected to grow at a strong 20.8% CAGR, increasing from USD 1.34 billion in 2024 to USD 4.12 billion by 2030, driven by... Read More

Published Date: DEC-2025 | No Of Pages:172 | $ 4485

CD70 Targeting Therapies Market By Therapy Type (Monoclonal Antibodies, Antibody-Drug Conjugates, CAR-T Cell Therapy, Bispecific Antibodies); By Indication (Renal Cell Carcinoma, Lymphomas, Acute Myeloid Leukemia, Others); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Academic & Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD70 Targeting Therapies Market is projected to grow at a strong CAGR of 17.4%, rising from USD 1.2 billion in 2024 to USD 3.1 billion by 2030, fueled by ... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Dysmenorrhea Treatment Market By Treatment Type (NSAIDs, Hormonal Therapy, Complementary Therapies, Surgical Intervention); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dysmenorrhea Treatment Market is projected to grow from USD 6.8 billion in 2024 to USD 10.1 billion by 2030, expanding at a 6.8% CAGR, driven by rising diagnosis rates, ho... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Fecal Microbiota Transplants (FMT) Market By Product Type (Traditional Fecal Suspensions, Processed Microbiota Formulations); By Route of Administration (Colonoscopy, Enema, Nasogastric/Nasoduodenal Tube, Oral Capsules); By End User (Hospitals, Specialty Clinics, Research Institutes, Stool Banks); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fecal Microbiota Transplants (FMT) Market is poised to witness a robust CAGR of approximately 1... Read More

Published Date: DEC-2025 | No Of Pages:191 | $ 4485

B-Cell Maturation Antigen (BCMA) Targeted Therapies Market By Therapy Type (CAR-T Cell Therapy, Bispecific Antibodies, Antibody-Drug Conjugates); By Indication (Multiple Myeloma, Lymphoma, Other B-cell Malignancies); By Line of Therapy (Third-line and Beyond, Earlier-line Settings); By End User (Academic Hospitals, Community Oncology Centers, Specialty Infusion Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market is projected to expand at a... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Autosomal Dominant Polycystic Kidney Disease Market By Drug Class (Vasopressin V2 Receptor Antagonists, Somatostatin Analogs, mTOR Inhibitors, Anti-Inflammatory & Antifibrotic Agents); By Diagnostic & Monitoring Tools (MRI/CT Imaging, Genetic Testing, Biomarker Platforms); By End User (Nephrology Clinics, Specialty Hospitals, Diagnostic/Imaging Centers, Digital Health & Home Monitoring Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autosomal Dominant Polycystic Kidney Disease (ADPKD) Market is projected to grow from $2.7 billion in 2024 to $3.8 billion by 2030 at a 5.9% CAGR, driven ... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Autosomal Dominant Optic Atrophy Market By Treatment Type (Gene Therapy, Supportive & Neuroprotective Therapies); By Diagnosis Stage (Early-Stage Diagnosis, Late-Stage Diagnosis); By End User (Academic Hospitals, Ophthalmology Clinics, Genetic Testing Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autosomal Dominant Optic Atrophy Market is estimated to reach around USD 143 million in 2024 and is projected to grow at a CAGR of 9.6% , ultimately surpassing USD... Read More

Published Date: DEC-2025 | No Of Pages:161 | $ 4485

Autoimmune Encephalitis Treatment Market By Treatment Type (Acute Immunotherapy, Maintenance Immunotherapy, Adjunctive Care); By Antibody Subtype (Anti-NMDA, LGI1, CASPR2, GABA, AMPA, Others); By End User (Tertiary Hospitals, General Hospitals, Neurology Clinics, Pediatric Centers, Infusion Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autoimmune Encephalitis Treatment Market is projected to grow at a robust CAGR of 8.1% , with an estimated value of USD 3.2 billion in 2024 and expected to reach U... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Atrophic Vaginitis Treatment Market By Treatment Type (Hormonal [Estrogen Tablets, Creams, Rings, SERMs], Non-Hormonal [Moisturizers, Hyaluronic Acid, Laser & RF Devices]); By Route of Administration (Topical, Oral, Device-Based); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online & Telehealth Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Atrophic Vaginitis Treatment Market is projected to reach $3.1 billion by 2030 , up from $1.9 billion in 2024 , growing at a CAGR of 8.5% over the forecas... Read More

Published Date: DEC-2025 | No Of Pages:181 | $ 4485

Astrocytoma Market By Grade (Low-Grade [Grade I & II], High-Grade [Grade III & IV]); By Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy); By End User (Hospitals, Oncology Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Astrocytoma Market is projected to grow from USD 2.1 billion in 2024 to USD 3.0 billion by 2030 at a 5.8% CAGR, driven by advances in neurosurgery, molecu... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Angioimmunoblastic T-cell Lymphoma Market By Therapy Type (Chemotherapy Regimens, Targeted Therapies, Monoclonal Antibodies & Biologics, Stem Cell Transplant); By Line of Therapy (First-Line, Second-Line and Beyond); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Angioimmunoblastic T -Cell Lymphoma Market is projected to expand at a CAGR of 8.1% , moving from an es... Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

Aneurysmal Subarachnoid Hemorrhage Market By Treatment Type (Endovascular Coiling, Surgical Clipping, Pharmacologic Therapy); By Drug Class (Calcium Channel Blockers, Vasodilators, Endothelin Receptor Antagonists, Neuroprotective Agents); By End User (Tertiary Stroke Centers, General Hospitals, Academic Medical Centers, Ambulatory Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aneurysmal Subarachnoid Hemorrhage Market is estimated to be worth USD 1.74 billion in 2024 , and it's projected to reach around Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

ANCA Associated Vasculitis Market By Disease Type (Granulomatosis with Polyangiitis, Microscopic Polyangiitis, Eosinophilic Granulomatosis with Polyangiitis); By Treatment Class (Corticosteroids, Immunosuppressants, Biologic Therapies, Plasma Exchange & Adjunct Therapies); By Route of Administration (Oral, IV, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global ANCA Associated Vasculitis (AAV) Market is forecast to expand steadily, with an inferred CAGR of 6.1% , valued at roughly USD 1.6 billion in 2024 and proj... Read More

Published Date: DEC-2025 | No Of Pages:189 | $ 4485

Alport Syndrome Market By Product Type (Pharmacological Therapies, Gene and Cell Therapies, Supportive Care); By Route of Administration (Oral, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alport Syndrome Market is projected to grow from USD 412 million in 2024 to nearly USD 615 million by 2030 at a 6.8% CAGR, driven by advances in genetic t... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Alpha-1 Antitrypsin Deficiency Market By Therapy Type (Augmentation Therapy, Gene Therapy, Small Molecule Drugs); By Route of Administration (Intravenous, Inhalation, Subcutaneous); By Disease Manifestation (Pulmonary, Liver, Others); By End User (Hospitals, Specialty Clinics, Home Infusion Services, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alpha-1 Antitrypsin Deficiency Market is projected to grow from USD 2.8 billion in 2024 to USD 4.1 billion by 2030 at a 6.3% CAGR, driven by augmentation ... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Alpha Thalassemia Treatment Market By Treatment Type (Blood Transfusions, Iron Chelation Therapy, Gene Therapy, HbF Inducers); By Disease Type (Alpha Thalassemia Trait, Hemoglobin H Disease, Hb Bart’s Hydrops Fetalis); By Route of Administration (Parenteral, Oral); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alpha Thalassemia Treatment Market is projected to grow at a 6.9% CAGR, rising from USD 536.4 million in 2024 to USD 802.7 million by 2030, driven by adva... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Alopecia Areata Market By Treatment Type (Topical Treatments, Oral/Systemic Treatments, Injectable Therapies, Biologics/Pipeline Drugs); By Patient Age Group (Pediatric, Adult); By End User (Hospitals and Specialty Clinics, Outpatient/Community Clinics, Telemedicine/Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alopecia Areata Market is projected to grow at a robust 7.8% CAGR, rising from USD 3.2 billion in 2024 to nearly USD 5.0 billion by 2030, driven by r... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

Alagille Syndrome Market By Treatment Type (Pharmacological Therapies, Surgical Interventions, Supportive Therapies); By Route of Administration (Oral, Parenteral/Hospital-Based); By End User (Hospitals & Specialty Centers, Diagnostic Laboratories, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alagille Syndrome Market is projected to grow at a 7.5% CAGR, rising from USD 0.46 billion in 2024 to nearly USD 0.76 billion by 2030, driven by orphan dr... Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Age Related Vision Dysfunction Market By Disorder Type (AMD, Cataracts, Glaucoma, Diabetic Retinopathy, Presbyopia); By Treatment Modality (Pharmacological, Surgical, Assistive Technologies, Diagnostic Imaging); By End User (Ophthalmology Clinics, Hospitals & ASCs, Retail Optometry Chains, Home-Based Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Age-Related Vision Dysfunction Market is projected to grow at a 6.8% CAGR, increasing from $23.5 billion in 2024 to $35.1 billion by 2030, driven by risin... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Advanced Renal Cell Carcinoma Market By Therapy Class (Tyrosine Kinase Inhibitors, mTOR Inhibitors, Immune Checkpoint Inhibitors, HIF-2α Inhibitors, Bispecifics and Others); By Line of Treatment (First-Line, Second-Line, Later Lines); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Advanced Renal Cell Carcinoma Market is projected to grow at a 7.8% CAGR, increasing from USD 9.6 billion in 2024 to USD 15.1 billion by 2030, driven by e... Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Adrenoleukodystrophy (ALD) Market By Disease Type (Cerebral ALD, Adrenomyeloneuropathy, Addison-only ALD); By Treatment Modality (Gene Therapy, Stem Cell Transplant, Hormone Replacement, Supportive Therapy, Diagnostics); By End User (Children’s Hospitals, Neurology Clinics, Diagnostic Labs, Endocrinology Centers, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Adrenoleukodystrophy (ALD) Market is gaining attention as diagnostic technologies, gene therapies, and newborn screening programs converge. Valued at USD 505 milli... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Adrenal Crisis Management Market By Product Type (Corticosteroid Injections, Auto-injectors & Prefilled Syringes, Oral Corticosteroids & Adjunct Therapies); By Route of Administration (Intravenous, Intramuscular / Subcutaneous); By End User (Hospitals & Emergency Departments, Ambulatory Clinics, Homecare, EMS Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Adrenal Crisis Management Market is projected to expand steadily, with an inferred CAGR of 6.1% , rising from an estimated USD 3.2 billion in 2024 to arou... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Acute Respiratory Distress Syndrome (ARDS) Treatment Market By Product Type (Mechanical Ventilation Systems, Extracorporeal Membrane Oxygenation, Pharmacologic Therapies, Adjunctive Care Tools); By Route of Administration (Intravenous, Inhalation, Emerging Routes); By End User (Hospitals & Intensive Care Units, Specialty & Academic Centers, General Hospitals, Emergency & Ambulatory Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market is projected to grow at a 6.2% CAGR, rising from USD 6.2 billion in 2024 to USD 8.9 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:198 | $ 4485

Acute Pancreatitis Market By Treatment Type (Supportive Care, Pharmacotherapy, Interventional & Surgical Procedures); By Etiology (Gallstone-Induced, Alcohol-Induced, Hypertriglyceridemia-Induced, Other/Idiopathic); By End User (Hospitals, Specialty Gastroenterology Centers, Ambulatory Surgical Centers, Long-Term Care Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Pancreatitis Market is projected to grow at a steady pace between 2024 and 2030, expanding from an estimated USD 5.8 billion in 2024 to nearly USD 8.6 billio... Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Acute on Chronic Liver Failure Market By Treatment Type (Pharmacological Therapy, Liver Support Systems, Organ Transplantation, Plasma Exchange); By End User (Tertiary Care Hospitals, Transplant Centers, Academic Medical Institutions, Specialty Liver Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute on Chronic Liver Failure ( ACLF ) Market is expected to grow at a CAGR of 9.0% , with a total valuation of approxi... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Acute Ocular Pain Market By Treatment Type (Topical NSAIDs, Topical Corticosteroids, Local Anesthetics, Neuropathic Pain Agents, Biologics); By Indication (Post-Operative Eye Pain, Corneal Abrasions & Injuries, Uveitis & Inflammatory Episodes, Chemical Burns, Neuropathic Ocular Pain); By Route of Administration (Topical Drops, Injectables, Oral Medications, Ocular Implants/Inserts); By End User (Ophthalmology Clinics, Hospital Emergency Departments, Ambulatory Surgical Centers, Retail Pharmacies, Teleophthalmology Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Ocular Pain Market to grow from USD 2.1 billion in 2024 to USD 3.1 billion by 2030 at a 6.4% CAGR, driven by rising ophthalmic surgeries, post-opera... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Acute Gout Flare Therapeutics Market By Drug Class (NSAIDs, Colchicine, Corticosteroids, Biologic Agents, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Gout Flare Therapeutics Market is projected to advance steadily, reaching an estimated value of USD 4.2 billion in 2024 and expanding to USD 6.1 billion by 2... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

Acute Coronary Syndrome Market By Type (STEMI, NSTEMI, Unstable Angina); By Drug Class (Antiplatelet Agents, Anticoagulants, Statins, Beta-Blockers, ACE Inhibitors/ARBs, Thrombolytics); By Device Type (Coronary Stents, Balloon Catheters, IVUS/OCT Imaging, Thrombectomy Devices, Diagnostics); By End User (Hospitals with PCI Facilities, EMS, Secondary Hospitals, Cardiology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Coronary Syndrome Market is projected to grow from USD 11.2 billion in 2024 to USD 16.7 billion by 2030 at a 6.8% CAGR, driven by rising cardiovascu... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market By Drug Class (Oxazolidinones, Lipoglycopeptides, Lipopeptides, Beta-lactams & Cephalosporins, Others); By Route of Administration (Intravenous, Oral, Long-Acting Injectable); By Infection Type (Cellulitis, Wounds, Abscesses, Trauma); By End User (Hospitals, ASCs, Outpatient Clinics, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Bacterial Skin and Skin Structure Infections Market is projected to expand steadily, valued at approximately USD 5.8 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Acid Sphingomyelinase Deficiency (ASMD) Market By Product Type (Enzyme Replacement Therapy, Gene Therapy Candidates, Supportive Care); By Application (Type A – Infantile Neurovisceral, Type B – Chronic Visceral, Type A/B Intermediate); By End User (Specialty & Tertiary Hospitals, Academic & Research Institutes, Home Infusion & Specialty Pharmacies, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acid Sphingomyelinase Deficiency Market will witness a strong growth trajectory, valued at USD 450 million in 2024 and projected to reach approximately Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Achondroplasia Market By Therapy Type (CNP Analogs, FGFR Inhibitors, Adjunctive & Supportive Care); By Patient Age Group (Pediatrics, Adults); By Route of Administration (Subcutaneous Injections, Oral Therapies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Achondroplasia Market will expand steadily between 2024 and 2030, with the market estimated at USD 1.1 billion in 2024 and projected to reach around USD 2.4 billio... Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485